GeoVax Secures Multi-Product License for ProBioGen’s AGE1.CR.pIX Suspension Cell Line to Bolster MVA-Based Vaccine Development
ATLANTA, GA and BERLIN, Germany – (Evertise AI PR) – September 26, 2023 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers, and ProBioGen announce the...